MLYS
Mineralys Therapeutics, Inc.Healthcare$26.97
▼ Bearish
Mkt Cap: $2.22B|Float: 60.5M|SI: 14.8%|DTC: 7.8
Data as of market close Apr 2, 2026
IV Rank
100
IV Pctl
89%
HV 20d
65.2%
52W Range
$10-$48
ATR(14)
$1.63
Exp. Move
±21.2%
P/C Ratio
2.91
Earnings
May 12
GEX Negative
DEX Long
Net Put Premium
IV High
Max Pain Below
Exp. Move Wide
High Put/Call
MLYS Key Options Data
- IV Rank
- 100%
- Total GEX
- $-0.00B
- Total DEX
- $1.3M
- Max Pain
- $25.00
- Expected Move
- ±21.2%
- Put/Call OI
- 2.91
- Net Premium
- $-0.4M
- Spot Price
- $26.97
Gamma Exposure (GEX)
Delta Exposure (DEX)
Expected Move by Expiration
| Expiration | DTE | Expected Move | Move % | Lower | Upper |
|---|---|---|---|---|---|
| 2026-04-17 | 15 | ±$5.72 | ±21.2% | $21.24 | $32.69 |
| 2026-05-15 | 43 | ±$3.40 | ±12.6% | $23.57 | $30.37 |
| 2026-06-18 | 77 | ±$10.22 | ±37.9% | $16.74 | $37.19 |
| 2026-09-18 | 169 | ±$13.40 | ±49.7% | $13.57 | $40.37 |
| 2026-12-18 | 260 | ±$8.85 | ±32.8% | $18.12 | $35.82 |
| 2027-01-15 | 288 | ±$16.60 | ±61.5% | $10.37 | $43.57 |
Explore MLYS options data including implied volatility rankings, gamma and delta exposure, max pain levels, and expected price moves. AI-generated reports provide directional, income, and earnings analysis.